In normal HSCs, the expression of ZNF521 rapidly diminishes, whereas in AML, and especially in those with MLL-rearrangements, expression remains elevated after oncogenic transformation [14,23,28,40,61,62]. Here, KMT2A is linked to acute myeloid leukemia.